Newfoundland and Labrador Calls for Fair and Equitable Implementation of National Pharmacare - Government of Newfoundland and Labrador

Nfld. & LabradorNewfoundland and Labrador’s health minister says reaching a pharmacare deal with the federal government is one of his highest priorities. That comes despite the federal health minister's past statement that deals with other provinces will expire. PCs not giving up on federal pharmacare deal despite past minister's assertion the feds shut the doorMark Quinn · CBC News · Posted: Oct 01, 2026 4:30 AM EDT | Last Updated: October 1Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Newfoundland and Labrador Health Minister Joedy Wall says signing on to the federal pharmacare program is a priority for the Progressive Conservative government. (Mark Quinn/ CBC)Newfoundland and Labrador's newly appointed health minister says reaching a pharmacare deal with the federal government is one of his highest priorities. "That was one of the top three things that was discussed when I came into the department was the pharmacare program," said Joedy Wall.

Our health-care system should not be a patchwork where some Canadians can access the medicine they need while others are left behind. The promise of pharmacare cannot be one where access depends on what province or territory you happen to call home, writes Gord Johns. Pexels photograph by Kampus Production

New studies of trends in the global burden of measles and pertussis offer a reminder of how much vaccination has achieved and a warning of the need to build more resilient and sustainable vaccination programs. This is a preview of subscription content, access via your institution

Chronic airway infection and inflammation form a destructive partnership in cystic fibrosis. Recent evidence shows that Pseudomonas aeruginosa persistent infections can redirect immunity towards tissue injury. Access Nature and 54 other Nature Portfolio journals